Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,218.00
(
1.73%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
98.48
(
1.81%
)
Bitcoin
78,260.90
(
0.03%
)
News Focus
News Focus
Post# of 257438
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 229113

Tuesday, 03/10/2020 7:02:24 PM

Tuesday, March 10, 2020 7:02:24 PM

Post# of 257438
Re: RVNC and COVID-19

RVNC’s CEO said on today’s Barclays webcast that RVNC has not seen any impact from COVID-19 on its clinical trials. Several of RVNC’s clinical trials, including the phase-3 ASPEN-1 study in CD, have enrolled and treated all patients and are now in observation mode.

The CEO also said that RVNC has hired most of its regional sales managers and that the Teoxane launch is still scheduled for 2Q20.

There is also no change in the 11/25/20 PDUFA date for RVNC's Daxi BLA in glabellar lines.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today